Stage IIIB Breast Cancer Active Not Recruiting Phase 3 Trials for Trastuzumab (DB00072)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02003209Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast CancerTreatment
NCT00770809Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by SurgeryTreatment